CD40LG and rheumatoid arthritis: Individuals that transitioned at 1 year from antibody negative to positive (either double RF-IgA and RF-IgM, CCP high, or both), had higher rates of incident clinical IA/RA than the negative at baseline group, while also having lower incidence than hypothetical individuals that were antibody positive from baseline (Figures 2A, B).